EW – edwards lifesciences corporation (US:NYSE)

DELAYED

^$ usd


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

1D

5D

1M

3M

YTD

1Y

3Y

1 Day EW SPY QQQ SPX

Date

Time

Symbol

Headline

Impact

Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]

Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System [Yahoo! Finance]

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Truist Financial Co. from $78.00 to $75.00. They now have a "hold" rating on the stock.

Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities [Yahoo! Finance]

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Date

Time

Symbol

Company Name

Action

%Chg

edwards lifesciences corporation

edwards lifesciences corporation

edwards lifesciences corporation

edwards lifesciences corporation

Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.

Date

Time

Action

From

To

Firm

Impact

%Chg

details

Canaccord Genuity

Royal Bank of Canada

Royal Bank of Canada

Date

Time

Symbol

Headline

Impact

Form 4 Edwards Lifesciences For: Apr 14 Filed by: BOBO DONALD E JR

Form DEFA14A Edwards Lifesciences

Form 4 Edwards Lifesciences For: Apr 08 Filed by: Lippis Daniel J.

Form 144 Edwards Lifesciences Filed by: Lippis Daniel J.

Form 4 Edwards Lifesciences For: Mar 26 Filed by: Ullem Scott B.

Form ARS Edwards Lifesciences For: Dec 31

Form DEFA14A Edwards Lifesciences

Form DEF 14A Edwards Lifesciences For: Dec 31

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size

Shares at ask / bid

Off exchange

Top News Gainers

3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%

7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%

4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%

3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%

4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%

4/13 Form DEFA14A Edwards Lifesciences 4.9%

3/25 Form DEFA14A Edwards Lifesciences 4.5%

4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%

10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%

2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%

Top News Decliners

1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%

4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%

3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%

4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%

10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%

4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%

4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%

3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%

9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%

3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: